Abstract:To the EditorWe present a case report of a 63-year-old man with ocular trauma admitted to the operating room for vitrectomy. He had medical history of hypertension, dyslipidemia, alcohol abuse, and chronic obstructive pulmonary disease Gold IIIC. He had been submitted to gastric suture under general anesthesia, 30 years ago with no known complications. He denied familial history of anesthetic complications. Pulmonary wheezing and rumbles were evident at auscultation. Standard American Society of Anesthesiologists monitorization was ensured and rapid sequence induction with propofol, fentanyl, and rocuronium was achieved. Sevoflurane was used for maintenance. Ninety minutes after induction, EtCO2 started to rise (60 mm Hg) with an obstructive capnography curve, increased airway pressure, and worsening of pulmonary wheezing at auscultation. Bronchospasm was assumed and treated with salbutamol, ipratropium bromide, hydrocortisone, magnesium sulfate, and ketamine. Despite treatment and ventilation adjustment, EtCO2 continued to rise until a maximum of 100 mm Hg. An arterial blood gas (ABG) analysis was obtained, showing acidosis (pH = 7.16) with hypercapnia (pCO2 = 88.7 mm Hg) and desaturation (SatO2 = 93.9%, with FiO2 = 60%, and pO2 = 88.6 mm Hg). Muscular rigidity became evident and temperature increased to a maximum of 40.5°C. The diagnosis of malignant hyperthermia was assumed. Sevoflurane was discontinued. High flow ventilation (FiO2 100%) and propofol perfusion were initiated. A dantrolene intravenous (iv) bolus (2.5 mg/kg) and 100 mL of 8.4% sodium bicarbonate were administered and active cooling measures initiated. An arterial line, central venous catheter, and urinary catheter were promptly placed. Venous blood samples were obtained to evaluate muscular enzymes, hepatic, and renal function. Intravenous crystalloids and 1 mg/kg furosemide were administered to maintain urine output and prevent renal injury. Noradrenaline infusion was started to maintain adequate median arterial pressures. ABG after starting therapeutic measures showed significant respiratory acidosis with severe hypercapnia (pH = 7.0, pCO2 = 156.9 mm Hg), without hypoxemia (PaO2 = 380 mm Hg with FiO2 = 100%), and a mild increase in lactate (2.7 mmol/L). Another iv bolus of dantrolene was given (total dose of 5 mg/kg). After a few minutes, temperature and EtCO2 started to drop. Forty-five minutes later, patient stabilized registering a core temperature of 37.2°C. Serialized ABG showed a progressive improvement in acidosis (pH = 7.355, pCO2 = 67.9 mm Hg). After stabilizing, he was taken to the intensive care unit (ICU) sedated with propofol and fentanyl, intubated and with a 24-hour iv infusion of dantrolene (0.25 mg/kg/h). In the ICU, muscular and hepatic enzymes gradually normalized, and renal function remained preserved. Patient was extubated on the third day, discharged from ICU on the fourth day and from the hospital 12 days after the procedure. Patient was referenced to follow-up anesthesiology and genetic consultations, where in vitro caffeine-halothane contracture and DNA tests confirmed the diagnosis of malignant hyperthermia (MH).

Almost-certain Malignant Hyperthermia During Cardiopulmonary Bypass: a Case Report and Literature Review

Treatment and nursing care of a patient diagnosed with malignant hyperthermia after general anesthesia: a case report

Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations

Emergency treatment of malignant hyperthermia during oral and maxillofacial surgery:Report of 2 consecutive cases

Diagnosis and rescue of malignant hyperthermia induced by anesthesia during radical surgery in a cervical cancer patient using the National Remote Emergency System: A case report

Malignant Hyperthermia: A Killer if Ignored.

[Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures]

Epidemiological and Clinical Features of Malignant Hyperthermia: A Scoping Review.

Malignant Hyperthermia

Spinal cord injury-related thermoregulatory impairment masks a fatal malignant hyperthermia crisis: a case report

Malignant hyperthermia: a case report with good outcome

Sudden Death Due to Malignant Hyperthermia with a Mutation of RYR1: Autopsy, Morphology and Genetic Analysis.

Malignant Hyperthermia-Like Syndrome in Acute Chlorfenapyr Poisoning – A Case Report

Nursing Interventions of Intraoperative Malignant Hyperthermia in Patients with Scoliosis: A Report of 3 Cases

Diagnosis and treatment of postoperative malignant hyperthermia in a pediatric patient with congenital myopathy due to RyR1 gene mutations

Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists

Pharmacokinetics of Dantrolene in the CVVH/PE Treatment of Malignant Hyperthermia in a 14-year-old Chinese Boy: A Case Report and Literature Review

Application of Caffeine-Halothane Contracture Test in the Diagnosis of Malignant Hyperthermia

Hyperthermia in a pediatric patient with neuroblastoma during anesthesia: a case report

Fatal Postoperative Malignant Hyperthermia Following Rhinoplasty in a Patient with One Variant of the Ryanodine Receptor 1 (RYR1) Gene.

Current State of Malignant Hyperthermia in China Mainland: a Less Optimistic Reality